Candida auris, an emerging fungal pathogen resistant to many antimicrobial agents, continues to threaten U.S. public health.
COLTENE is optimistic for the future despite a challenging financial year 2023 – Biotech Investments
COLTENE Holding AG / Key word(s): Preliminary Results 18-Jan-2024 / 06:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer